PMID- 22095727 OWN - NLM STAT- MEDLINE DCOM- 20120325 LR - 20211021 IS - 1524-4571 (Electronic) IS - 0009-7330 (Print) IS - 0009-7330 (Linking) VI - 110 IP - 1 DP - 2012 Jan 6 TI - Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. PG - 105-10 LID - 10.1161/CIRCRESAHA.111.254284 [doi] AB - RATIONALE: In rodents, infarct size after ischemia/reperfusion exhibits a circadian dependence on the time of coronary occlusion. It is not known if a similar circadian dependence of infarct size occurs in humans. OBJECTIVE: To determine if humans exhibit a circadian dependence of infarct size in the setting of ST elevation myocardial infarction (STEMI). METHODS AND RESULTS: A retrospective analysis of 1031 patients with STEMI referred for primary percutaneous coronary intervention with known ischemic times between 1 and 6 hours identified 165 patients with occluded arteries on presentation without evidence of preinfarction angina or collateral blood flow. Both ischemic duration and angiographic area at risk were not dependent on time of infarct onset. We observed that the extent of infarct size measured by creatine kinase release was significantly associated with time of day onset of infarction (P<0.0001). The greatest myocardial injury occurred at 1:00 am onset of ischemia and 5:00 am onset of reperfusion, with the peak creatine kinase measured at the peak of the curve being 82% higher than that recorded at the trough. Similarly, left ventricular ejection fraction measured within 2 days of infarction was also dependent on time of onset of STEMI with the absolute left ventricular ejection fraction at peak >7% higher than at trough (43% vs 51%; P<0.03). These findings were supported by a subgroup of patients (n = 45) who underwent cardiac MRI measurements of infarct size and area-at-risk measurements. CONCLUSIONS: The results of this study demonstrate for the first time in humans that myocardial infarct size and left ventricular function after STEMI have a circadian dependence on the time of day onset of ischemia. FAU - Reiter, Ronald AU - Reiter R AD - Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN 55407, USA. FAU - Swingen, Cory AU - Swingen C FAU - Moore, Luke AU - Moore L FAU - Henry, Timothy D AU - Henry TD FAU - Traverse, Jay H AU - Traverse JH LA - eng GR - R01 HL103927/HL/NHLBI NIH HHS/United States GR - R01 HL103927-02/HL/NHLBI NIH HHS/United States GR - 1-RO1HL103927/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20111117 PL - United States TA - Circ Res JT - Circulation research JID - 0047103 RN - EC 2.7.3.2 (Creatine Kinase, MB Form) SB - IM CIN - Circ Res. 2012 Jan 6;110(1):6-7. PMID: 22223205 CIN - Circ Res. 2012 Feb 3;110(3):e22; author reply e23. PMID: 22302758 CIN - Circ Res. 2012 Apr 27;110(9):e67; author reply e68. PMID: 22539760 CIN - Circ Res. 2013 May 10;112(10):e110-4. PMID: 23661713 CIN - Circ Res. 2013 May 10;112(10):e115-7. PMID: 23661714 CIN - Circ Res. 2013 Aug 2;113(4):e43-4. PMID: 23908336 MH - Aged MH - Circadian Rhythm/*physiology MH - Cohort Studies MH - Creatine Kinase, MB Form/metabolism MH - *Electrocardiography MH - Female MH - Humans MH - Magnetic Resonance Imaging MH - Male MH - Middle Aged MH - Myocardial Infarction/metabolism/*pathology MH - Myocardial Reperfusion Injury/metabolism/pathology MH - Retrospective Studies MH - Ventricular Function, Left/*physiology PMC - PMC3253266 MID - NIHMS342149 EDAT- 2011/11/19 06:00 MHDA- 2012/03/27 06:00 PMCR- 2013/01/06 CRDT- 2011/11/19 06:00 PHST- 2011/11/19 06:00 [entrez] PHST- 2011/11/19 06:00 [pubmed] PHST- 2012/03/27 06:00 [medline] PHST- 2013/01/06 00:00 [pmc-release] AID - CIRCRESAHA.111.254284 [pii] AID - 10.1161/CIRCRESAHA.111.254284 [doi] PST - ppublish SO - Circ Res. 2012 Jan 6;110(1):105-10. doi: 10.1161/CIRCRESAHA.111.254284. Epub 2011 Nov 17.